As of May 18
| +3.85 / +2.01%|
The 6 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 176.00, with a high estimate of 200.00 and a low estimate of 119.00. The median estimate represents a -9.74% decrease from the last price of 194.99.
The current consensus among 6 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.